Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOEP vs High-CHOEP in Aggressive Non-Hodgkin's Lymphoma
NCT00053768Phase 3Completed
- Sponsor
- German High-Grade Non-Hodgkin Lymphoma Study Group
- Start
- Apr 2002
- Primary completion
- Dec 2006
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of cyclophosphamide, doxorubicin, vincristine, etoposide, prednisone in non-Hodgkin lymphoma (NHL), sponsored by German High-Grade Non-Hodgkin Lymphoma Study Group. Started Apr 2002; status: completed.
02
Drugs
cyclophosphamidedoxorubicinvincristineetoposideprednisone
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00053768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00053768.